Senseonics Holdings Inc (SENS) Short Interest Update
Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 3,851,216 shares, a drop of 6.8% from the November 15th total of 4,131,161 shares. Based on an average daily volume of 309,620 shares, the days-to-cover ratio is presently 12.4 days. Currently, 7.9% of the company’s stock are short sold.
Shares of Senseonics (NYSEAMERICAN:SENS) opened at $2.58 on Tuesday. Senseonics has a 12 month low of $1.26 and a 12 month high of $3.67. The company has a current ratio of 2.93, a quick ratio of 2.81 and a debt-to-equity ratio of 0.76.
Senseonics (NYSEAMERICAN:SENS) last announced its quarterly earnings results on Tuesday, October 31st. The company reported ($0.13) EPS for the quarter, hitting analysts’ consensus estimates of ($0.13). Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The firm had revenue of $2.10 million during the quarter, compared to analyst estimates of $1.51 million. Senseonics’s quarterly revenue was up 425.0% compared to the same quarter last year. equities analysts expect that Senseonics will post -0.54 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently made changes to their positions in SENS. Renaissance Technologies LLC bought a new stake in Senseonics during the first quarter valued at approximately $111,000. Bank of New York Mellon Corp bought a new stake in Senseonics during the third quarter valued at approximately $116,000. Susquehanna International Group LLP bought a new stake in Senseonics during the second quarter valued at approximately $155,000. Perceptive Advisors LLC bought a new stake in Senseonics during the third quarter valued at approximately $160,000. Finally, LMR Partners LLP bought a new stake in Senseonics during the second quarter valued at approximately $177,000. Institutional investors own 30.66% of the company’s stock.
A number of brokerages have recently commented on SENS. Canaccord Genuity reiterated a “buy” rating on shares of Senseonics in a research note on Thursday, September 28th. Zacks Investment Research upgraded shares of Senseonics from a “sell” rating to a “hold” rating in a research note on Tuesday, August 15th.
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.